In this issue of Cancer Cell, Xue et al. demonstrate that adoptive transfer of tumor-specific Th9 cells can eradicate established tumors containing antigen-loss-variant cells (ALVs) through both direct killing and bystander effects mediated by intratumoral accumulation of extracellular ATP (eATP) that promotes monocyte infiltration and stimulation of IFNα/β production.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ccell.2021.10.013 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!